Vestar, Inc.
24Patents
0Active
24Granted
35Portfolio score
Filing activity: Oct 22, 1984 → Dec 14, 1994
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5019369A | Method of targeting tumors in humans | Emerging Cross-Sectional Technologies | 327 | Expired |
| US5411947A | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug | Chemistry; Metallurgy | 176 | Expired |
| US5463092A | Lipid derivatives of phosphonacids for liposomal incorporation and method of use | Chemistry; Metallurgy | 161 | Expired |
| US5227170A | Encapsulation process | Human Necessities | 128 | Expired |
| US4728575A | Contrast agents for NMR imaging | Human Necessities | 127 | Expired |
| US5320906A | Delivery vehicles with amphiphile-associated active ingredient | Emerging Cross-Sectional Technologies | 125 | Expired |
| US4946683A | Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes | Emerging Cross-Sectional Technologies | 105 | Expired |
| US5008109A | Vesicle stabilization | Emerging Cross-Sectional Technologies | 83 | Expired |
| US5484809A | Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid | Chemistry; Metallurgy | 75 | Expired |
| US4769250A | Antracycline antineoplastic agents encapsulated in phospholipid vesicle particles and methods for using same for tumor therapy | Chemistry; Metallurgy | 67 | Expired |
| US5089181A | Method of dehydrating vesicle preparations for long term storage | Emerging Cross-Sectional Technologies | 66 | Expired |
| US5258499A | Liposome targeting using receptor specific ligands | Human Necessities | 62 | Expired |
| US5186941A | Vesicle formulation for the controlled release of therapeutic agents | Emerging Cross-Sectional Technologies | 58 | Expired |
| US4877619A | Liposomal vesicles for intraperitoneal administration of therapeutic agents | Emerging Cross-Sectional Technologies | 53 | Expired |
| US4783220A | Vesicle ink compositions | Chemistry; Metallurgy | 45 | Expired |
| US5441745A | Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5527538A | Liposomal targeting of ischemic tissue | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4935171A | Method for vesicle formation | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5328678A | Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy | Human Necessities | 14 | Expired |
| US5411743A | Prevention of synovial adhesions | Human Necessities | 14 | Expired |
| US4963363A | Phospholipid delivery vehicle for aqueous-insoluble active ingredients | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5435989A | Method of targeting a specific location in a body | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5028297A | Film-forming evaporation apparatus | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5419914A | Phospholipid analogue vesicle | Emerging Cross-Sectional Technologies | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.